Leif E Wide

Title: Leif E Wide: Innovator in Rheumatoid Factor Indication

Introduction

Leif E Wide is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of diagnostics, particularly in the indication of rheumatoid factors. With a total of two patents to his name, his work has implications for medical diagnostics and patient care.

Latest Patents

Leif E Wide's latest patents focus on methods for indicating rheumatoid factors in aqueous samples. The first patent describes a method that utilizes the complement factor C1q in non-bound form to selectively precipitate rheumatoid factors that can react with aggregated immunoglobulin. This innovative approach allows for the detection of rheumatoid factors belonging to immunoglobulin classes other than IgM. The second patent outlines a method for indicating rheumatoid factors belonging to IgM, IgG, and IgA classes. In this method, any complement factor C1q present in the sample is pacified, and the sample is reacted with aggregated immunoglobulin to form detectable aggregates.

Career Highlights

Leif E Wide has been associated with Pharmacia Diagnostics AB, where he has contributed to advancements in diagnostic methods. His work has been instrumental in enhancing the accuracy and reliability of tests for rheumatoid factors, which are crucial for diagnosing autoimmune conditions.

Collaborations

Leif collaborates with Henning R Hallgren, a fellow professional in the field. Their combined expertise has likely contributed to the development of innovative diagnostic solutions.

Conclusion

Leif E Wide's contributions to the field of diagnostics, particularly in the indication of rheumatoid factors, highlight his role as an important inventor. His patents reflect a commitment to improving medical diagnostics and patient outcomes.